Table 1 Demographic characteristics, etiology, management, and outcomes of patients with vancomycin-resistant endophthalmitis due to Gram-positive bacteria
Serial number | Age (years) | Sex | Etiology | Duration (days) | Presenting V/A | Primary intervention | Secondary intervention | Smear | Systemic antibiotic | Intravitreal antibiotic | Intravitreal steroid | Final V/A | Follow-up (months) | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 20 | M | Trauma | 1 | LP | CTR + PPV + IOAB | PPV + M + C + T | GPB | Ciprofloxacin | V + C | T | CF - 1 m | 3 | Unfavorable |
2 | 70 | F | Postcataract surgery | 5 | LP | PPV + IOAB + IOL explant | Nil | GPC | Gatifloxacin | V + A | D | LP | 3 | Unfavorable |
3 | 70 | M | Postcataract surgery | 1 | LP | PPV + IOAB | C + T | GPB | Ciprofloxacin | V + A | T | 20/20p | 4 | Favorable |
4 | 5 | M | Trauma | 1 | LP | CTR + PPL + PPV + IOAB | Nil | GPB | Cephalexin | V + C + Am | - | LP | 6 | Unfavorable |
5 | 4 | F | Trauma | 3 | HM | CTR + PPL + PPV + IOAB | Nil | GPB | Ciprofloxacin | V + C | - | LP | 3 | Unfavorable |
6 | 60 | M | Postcataract surgery | 6 | LP | PPV + IOAB | Nil | GPC | Ciprofloxacin | V + C | - | LP | 6 | Unfavorable |
7 | 16 | F | Endogenous | 20 | LP | PPV + IOAB | Enucleation | GPC | Ciprofloxacin | V + A | - | NLP | 6 | Unfavorable |